Dr. Angela Marie Mills, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 1801 16th St, Greeley, CO 80631 Phone: 970-481-0170 Fax: 970-481-0170 |
Dr. Oscar Levern Sanders Ii, General Practice Medicare: Medicare Enrolled Practice Location: 6767 W 29th Street, Greeley, CO 80634 Phone: 970-652-2474 Fax: 970-652-2418 |
Dr. Thomas J Lynch, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1900 16th St, Greeley, CO 80631 Phone: 970-350-2471 Fax: 970-350-2418 |
Dr. Leslie A Leppla, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 900 14th St, Greeley, CO 80631 Phone: 970-356-3993 |
Sami Houssin Hourieh, MD General Practice Medicare: Medicare Enrolled Practice Location: 1600 23rd Ave, Greeley, CO 80634 Phone: 970-810-2815 |
News Archive
Treena Livingston Arinzeh, PhD, of West Orange, a professor of biomedical engineering at New Jersey Institute of Technology (NJIT), received an Innovators Award from the New Jersey Inventors Hall of Fame (NJIHoF) in recognition of her research and inventions utilizing biomaterials and regenerative medicines for orthopedic and neural disorders.
How different are men and women's brains? The latest evidence to address this controversy comes from a study at Rosalind Franklin University of Medicine and Science, where a meta-analysis of human amygdala volumes found no significant difference between the sexes.
Researchers at the University of Louisville, Kentucky, have demonstrated that a new radiotracer, 2-18F-fluorodeoxysorbitol (18F-FDS), can identify and track bacterial infection in lungs better than current imaging methods and is able to differentiate bacterial infection from inflammation.
Soft robots that are incredibly light and foldable and can lift weights that are over 1,000 times their own weight and these are also cheap and easy to make costing less than a dollar in making charges.
Columbia Laboratories, Inc. and Watson Pharmaceuticals, Inc. today announced positive top-line results from the PREGNANT Study, a large, global Phase III clinical trial evaluating PROCHIEVE® 8% vaginal progesterone gel to reduce the risk of preterm birth in women with a short cervical length as measured by transvaginal ultrasound at mid-pregnancy.
› Verified 9 days ago